Share This Page
Suppliers and packagers for generic pharmaceutical drug: BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
✉ Email this page to a colleague
BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Leo Pharma As | ENSTILAR | betamethasone dipropionate; calcipotriene | AEROSOL, FOAM;TOPICAL | 207589 | NDA | LEO Pharma Inc. | 50222-302-60 | 1 CAN in 1 CARTON (50222-302-60) / 60 g in 1 CAN | 2015-10-16 |
| Leo Pharma As | ENSTILAR | betamethasone dipropionate; calcipotriene | AEROSOL, FOAM;TOPICAL | 207589 | NDA | LEO Pharma Inc. | 50222-302-66 | 2 CAN in 1 CARTON (50222-302-66) / 60 g in 1 CAN | 2015-10-16 |
| Leo Pharma As | ENSTILAR | betamethasone dipropionate; calcipotriene | AEROSOL, FOAM;TOPICAL | 207589 | NDA | LEO Pharma Inc. | 50222-302-91 | 1 CAN in 1 CARTON (50222-302-91) / 60 g in 1 CAN | 2015-10-16 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
Suppliers for the Pharmaceutical Drugs: Betamethasone Dipropionate and Calcipotriol
Introduction
The pharmaceutical landscape for topical therapies prominently features Betamethasone Dipropionate and Calcipotriol — two agents with widespread use in managing inflammatory and dermatologic conditions such as psoriasis and eczema. The global supply chain for these drugs encompasses a range of manufacturers, distributors, and branded or generic suppliers. Understanding the key players involved, their regulatory standing, and market dynamics is crucial for stakeholders seeking reliable sources.
Overview of Betamethasone Dipropionate and Calcipotriol
Betamethasone Dipropionate is a potent corticosteroid used primarily topically to treat inflammatory skin disorders. Its efficacy depends on consistent quality control, especially because potency variations can significantly influence treatment outcomes and adverse effects.
Calcipotriol, a vitamin D analog, modulates epidermal cell proliferation and differentiation, making it a cornerstone medication for psoriasis management. Its stability, bioavailability, and formulation quality are critical to therapeutic success.
Both drugs are frequently combined in formulations, such as ointments and creams, to capitalize on synergistic effects. Therefore, suppliers often provide both as monotherapies or combination medicines.
Major Suppliers of Betamethasone Dipropionate
1. Mylan (now part of Viatris)
Mylan has a robust portfolio of corticosteroids, including Betamethasone Dipropionate. They supply both branded and generic versions globally, maintaining compliance with regulatory agencies such as the FDA and EMA. Their manufacturing facilities are ISO-certified, ensuring consistent quality.
2. Glenmark Pharmaceuticals
Glenmark is a leading Indian pharmaceutical company manufacturing Betamethasone Dipropionate formulations. Their products are approved in various markets, including India, Latin America, and parts of Southeast Asia, with growing interest elsewhere.
3. Sun Pharma
Sun Pharma produces topical corticosteroids, including Betamethasone Dipropionate. Their extensive distribution channels serve emerging markets and fit within global supply chains.
4. Dr. Reddy’s Laboratories
Dr. Reddy’s offers Betamethasone Dipropionate-based products in multiple formulations, supplying both Indian domestic and international markets.
5. Sandoz (a Novartis division)
Sandoz supplies generic corticosteroid formulations with high regulatory standards, catering to markets that demand high-quality generics compliant with international standards.
Leading Suppliers of Calcipotriol
1. Leo Pharma
Leo Pharma pioneered the development of Calcipotriol in topical treatments. They continue to be a primary supplier, offering high-purity formulations suited for both branded and generic products worldwide.
2. Dr. Reddy’s Laboratories
Dr. Reddy’s manufactures Calcipotriol formulations, focusing on a broad portfolio that includes combination products with Betamethasone Dipropionate, available across diverse markets.
3. Mankind Pharma
An Indian pharmaceutical giant, Mankind Pharma produces Calcipotriol in various topical forms, targeting both developing and developed markets.
4. Systopic
Specialized in dermatological drugs, Systopic supplies Calcipotriol in various formulations, often focusing on emerging markets.
5. Teva Pharmaceuticals
Through its generic portfolio, Teva offers Calcipotriol formulations globally, emphasizing quality and affordability.
Global Regulatory and Manufacturing Considerations
The supply chain's integrity hinges critically on compliance with regulatory bodies like the FDA (USA), EMA (Europe), and similar authorities in other regions. Suppliers with WHO GMP certification and approval from local agencies tend to have more reliable and consistent access to international markets. Contract manufacturing organizations (CMOs), especially in India and China, dominate the production landscape due to cost advantages but require rigorous oversight to ensure quality.
Market Dynamics and Supply Chain Challenges
The demand for Betamethasone Dipropionate and Calcipotriol remains stable due to their essential role in dermatology. However, supply chain disruptions are common due to factors like raw material shortages, regulatory hurdles, and geopolitical influences. Suppliers with diversified manufacturing sites and strategic stockpile management are better equipped to mitigate such risks.
Furthermore, approvals for biosimilars and generics have intensified competition, influencing pricing and supply reliability. Large pharmaceutical firms with established global distribution networks tend to dominate, but niche and regional suppliers continue to serve local markets effectively.
Emerging Sources and Strategic Considerations
Emerging suppliers from India, China, and Southeast Asia have gained market share by offering cost-competitive formulations that meet international quality standards. Companies such as Aurobindo Pharma, Cipla, and Hetero Drugs are also active in producing these agents.
Stakeholders should consider:
- Regulatory approvals and certifications
- Manufacturing capacity and scalability
- Supply chain transparency
- Quality management systems
Building relationships with reliable suppliers who possess valid Good Manufacturing Practice (GMP) certifications and robust supply chain logistics ensures drug integrity and consistent availability.
Conclusion
Procurement of Betamethasone Dipropionate and Calcipotriol involves engaging with well-established global pharmaceutical manufacturers and regional suppliers, each with varying operational strengths. Leading firms like Mylan (Viatris), Leo Pharma, and Dr. Reddy’s maintain a dominant presence through their extensive production and distribution networks. The complexity of the global supply chain underscores the importance of rigorous supplier qualification, regulatory compliance, and contingency planning.
Key Takeaways
- Multiple global and regional suppliers provide Betamethasone Dipropionate and Calcipotriol, with leading players maintaining high-volume and high-quality production.
- Indian pharmaceutical companies such as Dr. Reddy’s, Mankind Pharma, and Cipla are prominent sources, especially for emerging markets.
- Regulatory compliance, including WHO GMP certification, remains fundamental to ensuring supply reliability and product quality.
- Supply chain stability is sensitive to raw material availability, geopolitical factors, and manufacturing disruptions, necessitating diversified sourcing strategies.
- Strategic partnerships with certified, scalable manufacturers mitigate risk, ensuring continuous supply to meet global demand.
FAQs
1. Are generic versions of Betamethasone Dipropionate and Calcipotriol as effective as brand-name formulations?
Yes, when manufactured in compliance with regulatory standards, generic versions are bioequivalent and therapeutically equivalent to branded formulations, often at a lower cost.
2. Which regions have the most reliable supply sources for these drugs?
North America and Europe benefit from a well-established regulatory environment ensuring high-quality supply sources. India and China are major manufacturing hubs supplying both local and international markets.
3. What are the key considerations when choosing a supplier for these drugs?
Regulatory compliance (GMP certifications), manufacturing capacity, quality control measures, supply chain reliability, and cost competitiveness are critical factors.
4. How do recent regulatory changes impact the supply of Betamethasone Dipropionate and Calcipotriol?
Stringent quality standards and increased regulatory oversight can affect manufacturing processes and approval times but ultimately improve drug safety and efficacy.
5. Are there any upcoming alternatives or innovations in topical corticosteroids and vitamin D analogs?
Research continues into more targeted delivery systems, biosimilars, and combination formulations aimed at improving efficacy and safety profiles, potentially affecting future supplier dynamics.
References
- [1] Pharmacovigilance and drug safety reports. International Pharmaceutical Regulators Forum (IPRF).
- [2] Market analysis reports on topical corticosteroids and vitamin D analogs. IQVIA.
- [3] U.S. Food and Drug Administration (FDA) drug approvals database.
- [4] European Medicines Agency (EMA) product approvals.
- [5] World Health Organization (WHO) GMP certification standards.
More… ↓
